Characterization of Precursor and Secreted Forms of Rat Angiotensinogen*
- 1 March 1984
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 114 (3) , 776-785
- https://doi.org/10.1210/endo-114-3-776
Abstract
Angiotensinogen precursors synthesized by rabbit reticulocyte lysate primed with rat liver RNA were compared with angiotensinogen secreted by rat hepatoma cells and rat hepatocytes using immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Inhibition of glycosylation with tunicamycin permittted identification of the nonglycosylated form of secreted angiotensinogen. While angiotensinogen secreted by hepatoma cells and hepatocytes showed electrophoretic heterogeneity (MW, 52-62 .times. 103), tunicamycin-treated cells secreted only a single angiotensinogen species [MW, 48.3 .+-. 0.7 .times. 103 (mean .+-. SD)], which could be cleaved by renin. Two putative angiotensinogen precursors were synthesized in the reticulocyte lysate: a major protein of 52.5 .+-. 1.0 .times. 103 MW II and a minor protein of 55.7 .+-. 1.3 .times. 103 MW. Evidence that these proteins represent separate angiotensinogen precursors includes the following. Both proteins were recognized by 5 different polyclonal antibodies and 2 monoclonal antibodies. Both proteins increased in parallel in reticulocyte lysates primed with liver RNA from rats nephrectomized and given hormones that increase liver angiotensinogen production. Both proteins were cleaved by renin to produce a single protein of 47.6 .+-. 0.8 .times. 103 MW. The des-angiotensin I-angiotensinogen generated by renin treatment of the lysate had an electrophoretic mobility identical to that of des-angiotensin I-angiotensinogen produced by renin treatment of nonglycosylated angiotensinogen secreted by tunicamycin-treated hepatoma cells and hepatocytes. Apparently rat liver synthesizes 2 separate angiotensinogen precursors which may differ only in the size of their prepro sequence. The heterogeneity of secreted angiotensinogen can be fully accounted for by differences in N-glycosylation of asparagine residues of the molecule. Glycosylation of angiotensinogen is not essential for its synthesis, processing and secretion or its hydrolysis by renin.This publication has 27 references indexed in Scilit:
- Multiple forms of human plasma renin substrate.Journal of Clinical Investigation, 1978
- Effect of tunicamycin on the secretion of serum proteins by primary cultures of rat and chick hepatocytes. Studies on transferrin, very low density lipoprotein, and serum albuminJournal of Biological Chemistry, 1978
- Purification of human renin substrateAnalytical Biochemistry, 1978
- An Efficient mRNA‐Dependent Translation System from Reticulocyte LysatesEuropean Journal of Biochemistry, 1976
- Characterization of mannose-labeled glycopeptides from human diploid cells and their growth-dependent alterations.Journal of Biological Chemistry, 1976
- THE PREPARATION, PURIFICATION, AND AMINO ACID SEQUENCE OF A POLYPEPTIDE RENIN SUBSTRATEThe Journal of Experimental Medicine, 1957
- THE AMINO ACID COMPOSITION OF HYPERTENSIN II AND ITS BIOCHEMICAL RELATIONSHIP TO HYPERTENSIN IThe Journal of Experimental Medicine, 1956
- Changes in Hypertensinase and Hypertensinogen Following NephrectomyCirculation Research, 1954
- THE EFFECT OF THE ADMINISTRATION OF ESTROGENS ON THE RENIN-SUBSTRATE (HYPERTENSINOGEN) CONTENT OF RAT PLASMAEndocrinology, 1952
- BIOLOGICAL ACTIVITY OF STEROIDS AS DETERMINED BY ASSAY OF RENIN-SUBSTRATE (HYPERTENSINOGEN)Endocrinology, 1951